News
Axios on MSN46m
Drugmaker refuses FDA request to pull gene therapyAn unusual public feud between the Food and Drug Administration and a maker of gene therapies for rare diseases could test ...
Sarepta stock (SRPT) declined 5% in premarket trade, after falling 36% on Friday, when it disclosed a patient death due to liver failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback